Latest AusBiotech News | Page 11

Imugene appoints experienced executive as new chief financial officer
Cynata Therapeutics secures US patent for Use of Cymerus MSCs in Asthma
Actinogen confirms Alzheimer’s disease biomarker study timing and design
NeuroScientific Biopharmaceuticals seeks approval for phase 1 trial
ResApp Health extends agreement with Europe’s Medgate
Botanix Pharmaceuticals accelerates filing of NDA
AusBiotech and CSIRO partner to connect sector
CSIRO supports CUREator with funding for health security stream
Dimerix updates with new and positive DMX-700 data
Funding programme increases support for WA researchers
Novotech secures regional ‘Best Biologics CRO’ award
Starpharma’s anti-viral nasal spray relaunched in UK
New leadership for medtech regulatory advisory group
Lumos Diagnostics secures authorisation for test in Canada
Starpharma signs expanded DEP research agreemnent with Genentech
Investment funds support university commercialisation
Victorian government to grant to Hudson Institute for collaboration with Noxopharm
Volpara Health in new collaboration with Microsoft
NSW & QLD Government investments into industry welcomed
New orphan drug designation for Kazia Therapeutics’ paxalisib
Life sciences industry says IP waiver an ’empty shell’ and fact-free decision
High appetite for biotech VC cited in new report
Major software acquisition for leading Australian company ResMed
Registrations are open to ‘come alive’ at AusBiotech 2022
NeuroScientific Biopharmaceuticals reports positive data from animal study
Telix and RefleXion expand partnership for prostate cancer treatment
Regeneus chief executive makes off-market investment in company
Significant growth symbolic of biotech sector’s sovereign value
Dimerix enters agreement for new trial of DMX-200 in diabetic kidney disease
Clarity secures US IND approval for phase 2 prostate cancer trial
Immutep reports positive overall response rate in lung cancer trial
Mission to United States to promote WA
First patient recruited in Dimerix late-stage trial
New appointment to Imugene’s scientific advisory board
One-stop shop for clinical trials enters its second phase
Adherium provides update on senior management
Cynata Therapeutics adds new site for MEND clinical trial
Profile successes and add your voice
Archer Materials secures Australian patent for quantum computing chip
New clinical trial to test cancer drug in motor neuron disease
Thriving medtech community celebrated at record-breaking AusMedtech 2022
AusBiotech welcomes incoming Federal Government
AnteoTech’s updated Covid RAT receives regulatory approval in Europe
FDA confirms diagnostic method for Medibio’s final depression validation trial
Illumina’s Susan Tousi on genomics and changing healthcare
Nyrada says European patent to be granted for cholesterol-lowering drug
PharmAust says MPL tablets arrive for Motor Neuron Disease trial
Help AusBiotech 2022 programme ‘Come Alive’